In two other studies, mutations in the LDL receptor gene were introduced through AAV-mediated CRISPR guide RNA delivery that rather induced a deletion of normal protein functioning and led to the subsequent development of hypercholesterolemia in genetically normolipidemic wild-type or Cas9 transgenic mice [16, 17]. The gene discussed is LDLR; the disease is Hypercholesterolemia.